Bleichroeder LP’s Voyager Therapeutics VYGR Stock Holding History

Bleichroeder LP’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,029	Closed	-$293K	–	61
2019 Q4	$293K	Buy	+21,029	New	+$306K	0.05%	40

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bleichroeder LP's VYGR Position: Q1 2020 in Review

Bleichroeder LP sold out of Voyager Therapeutics (VYGR) in Q1 2020, closing a stake of 21,029 shares — an estimated $293K sold.

Bleichroeder LP first reported a position in VYGR in Q4 2019 and held it in 1 quarter. The position peaked at $293K in Q4 2019. 121 funds tracked by Wall St. Rank hold VYGR as of Q1 2020.

Bleichroeder LP reported no remaining Voyager Therapeutics position as of Q1 2020 after selling out during the quarter.
Bleichroeder LP sold 21,029 Voyager Therapeutics shares in Q1 2020, an estimated $293K.
Bleichroeder LP first reported a position in Voyager Therapeutics in Q4 2019 and held it in 1 quarter.
Bleichroeder LP's Voyager Therapeutics position peaked at $293K in Q4 2019.
121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2020.

Based on Bleichroeder LP's 13F filing for Q1 2020, filed 14 May 2020.